Who owns TRANSMEDICS GROUP INC?
- CUSIP Number: 89377mab5
Tip: Access positions for across all investors
Analyze quarterly positions in Transmedics Group with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Transmedics Group stock
Who bought or sold TRANSMEDICS GROUP INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 74M | $96M | 100% | Mar 2026 |
|
| Wolverine Asset Management | 67M | $86M | 7% | Mar 2026 |
|
| Tenor Capital Management | 48M | $62M | -20% | Mar 2026 |
|
| Opti Capital Management | 35M | $45B | 0% | Mar 2026 |
|
| DeepCurrents Investment Group | 31M | $40M | 0% | Mar 2026 |
|
| Readystate Asset Management | 30M | $39M | 0% | Mar 2026 |
|
| Two Sigma Investments | 30M | $39M | -15% | Mar 2026 |
|
| OZ Management | 28M | $36M | 10% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 22M | $28M | 66% | Mar 2026 |
|
| Linden Advisors | 16M | $21M | -70% | Mar 2026 |
|
| Lazard Asset Management | 13M | $170k | 28% | Mar 2026 |
|
| Aristeia Capital | 10M | $13M | 0% | Mar 2026 |
|
| State Street Corporation | 9.4M | $12M | -5% | Mar 2026 |
|
| Citigroup | 8.7M | $11M | 100% | Mar 2026 |
|
| BlackRock | 7.2M | $9.3M | 34% | Mar 2026 |
|
| Nuveen | 5.5M | $7.1M | 100% | Mar 2026 |
|
| FMR | 5.4M | $7.0M | 0% | Mar 2026 |
|
| Zazove Associates | 4.5M | $4.9M | 80% | Jun 2026 |
|
| Gabelli Funds | 3.9M | $5.0M | 0% | Mar 2026 |
|
| Franklin Resources | 2.6M | $3.4M | 29% | Mar 2026 |
|
| Calamos Advisors | 2.6M | $3.3M | -9% | Mar 2026 |
|
| Lord, Abbett & Co | 2.2M | $2.9M | 3% | Mar 2026 |
|
| Invesco | 2.0M | $2.6M | 0% | Mar 2026 |
|
| Morgan Stanley | 950k | $1.2M | 0% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 800k | $1.0M | 0% | Mar 2026 |
|
| Agf Management | 775k | $1.0M | -40% | Mar 2026 |
|
| Bank of America Corporation | 698k | $902k | 100% | Mar 2026 |
|
| GAMCO Asset Management | 260k | $336k | 0% | Mar 2026 |
|
| Barclays | 73k | $95k | 170% | Mar 2026 |
|
| UBS Group | 53k | $68k | -94% | Mar 2026 |
|
| Branch Banking & Trust Company | 30k | $32k | 0% | Jun 2026 |
|
| Boussard & Gavaudan Investment Management | 4.0k | $5.2M | 100% | Mar 2026 |
|
| Wells Fargo & Company | 2.0k | $2.6k | 0% | Mar 2026 |
|
| Steward Partners Investment Advisory | 2.0k | $2.6k | 0% | Mar 2026 |
|
| Loomis, Sayles and | 2.0k | $196k | 131% | Mar 2026 |
|
Who sold out of Transmedics Group?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 26M | $38M |
| Aequim Alternative Investments | Dec 2025 | 10M | $15M |
| Leucadia National Corporation | Dec 2025 | 1.7M | $2.5M |
| Bank of New York Mellon | Dec 2025 | 150k | $226k |